Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.64%
0%
-14.64%
6 Months
5.96%
0%
5.96%
1 Year
2.57%
0%
2.57%
2 Years
-14.39%
0%
-14.39%
3 Years
-53.35%
0%
-53.35%
4 Years
-75.09%
0%
-75.09%
5 Years
-59.61%
0%
-59.61%
PharmaBlock Sciences (Nanjing), Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.38%
EBIT Growth (5y)
4.40%
EBIT to Interest (avg)
36.57
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.37
Tax Ratio
10.97%
Dividend Payout Ratio
25.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.85%
ROE (avg)
11.32%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
2.12
EV to EBIT
36.03
EV to EBITDA
21.55
EV to Capital Employed
2.19
EV to Sales
4.06
PEG Ratio
1.72
Dividend Yield
0.61%
ROCE (Latest)
6.07%
ROE (Latest)
5.33%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
459.10
449.30
2.18%
Operating Profit (PBDIT) excl Other Income
77.50
75.70
2.38%
Interest
13.00
13.70
-5.11%
Exceptional Items
0.70
-1.10
163.64%
Consolidate Net Profit
36.70
35.80
2.51%
Operating Profit Margin (Excl OI)
93.10%
91.20%
0.19%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 2.18% vs -19.25% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 2.51% vs -59.18% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,666.80
1,706.60
-2.33%
Operating Profit (PBDIT) excl Other Income
357.10
380.80
-6.22%
Interest
62.30
68.20
-8.65%
Exceptional Items
8.00
-32.70
124.46%
Consolidate Net Profit
219.50
197.40
11.20%
Operating Profit Margin (Excl OI)
130.80%
151.90%
-2.11%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -2.33% vs 7.82% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 11.20% vs -39.43% in Dec 2023
About PharmaBlock Sciences (Nanjing), Inc. 
PharmaBlock Sciences (Nanjing), Inc.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available






